Fri, 07/12/2019 - 11:02
Oliver Sexton, Investment Director, and Pablo Lubroth, Investment Manager, UK Innovation and Science Seed Fund (UKI2S), share their thoughts on the recent SynbiTECH 2019 conference in London.
"The global synthetic biology sector is growing rapidly; 2018 saw 98 synthetic biology companies raise a record $3.8 billion in venture capital, new IPOs, post-equity investments, and secondary market offerings – in comparison to $1.8 billion in 2017. SynbiTECH2019, a two-day conference that took place 24-25 June in London, was the ideal opportunity for this growth and innovation to be showcased. The event saw companies, delegates and speakers from around the world come together to discuss the key opportunities and challenges for building a multibillion-dollar synthetic biology industry that will contribute to the fast-growing bio-economy."
Read the full article here.